一个精细的薄膜模型,用于药物溶解,考虑辐射扩散 - 模拟粉末溶解
Karthik Salish1, Chi So1, Seong Hoon Jeong2
1Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Pharmaceutical research
|April 8, 2024
概括
一个精致的薄膜模型准确地描述了药物粉末的溶解,性能优于传统模型. 该研究强调,并非所有粒子表面都会导致溶解,并警告不要使用特定的表面积进行预测.
科学领域:
- 制药科学 制药科学
- 物理化学 物理化学
- 材料科学 材料科学 材料科学
背景情况:
- 药物颗粒溶解的准确建模对于配方开发至关重要.
- 现有的模型往往简化了扩散过程和粒子行为.
- 了解溶解动力学可以告知药物输送和生物可用性.
研究的目的:
- 完善用于药物颗粒溶解的薄膜模型,将辐射扩散纳入球形边界层.
- 为了证明模型在描述散装药物粉末的溶解行为方面的能力.
- 为了比较精细模型的性能与经典的溶解形式主义.
主要方法:
- 改进了以前建立的基于辐射扩散的模型.
- 模拟散装粉末溶解,考虑变化的颗粒大小和扩散层厚度.
- 在实验室溶解测试分离的酸粉末,以验证模型.
主要成果:
- 改进后的模型与各种甲颗粒大小的实验溶解数据有很好的一致性.
- 该模型倾向于过度预测较小粒子的溶解速率.
- 经典的Nernst-Brunner模型低估了溶解速率,而特定的表面积计算过度预测了它们.
结论:
- 基于辐射扩散的薄膜模型有效地描述了药物粉末的溶解.
- 由于其转化扩散假设,Nernst-Brunner方程可能低估了溶解.
- 单独的特定表面积并不是由于非贡献表面而导致药物溶解的可靠预测指标.
相关概念视频
Theories of Dissolution: Diffusion Layer Model
744
Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
744
Theories of Dissolution: The Danckwerts' Model and Interfacial Barrier Model
293
Various dissolution theories provide insight into the factors that influence the dissolution rate. Danckwerts' Model suggests that turbulence, rather than a stagnant layer, characterizes the dissolution medium at the solid-liquid interface. In this model, the agitated solvent contains macroscopic packets that move to the interface via eddy currents, facilitating the absorption and delivery of the drug to the bulk solution. The regular replenishment of solvent packets maintains the...
293
Factors Affecting Dissolution: Particle Size and Effective Surface Area
826
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
826
Factors Influencing Drug Absorption: Drug Dissolution
480
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
480
Factors Influencing Drug Absorption: Pharmaceutical Parameters
133
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
133
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
202
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
202


